Ebola virus disease
The pathogenesis of Ebola Virus Disease
Laura Baseler, Daniel S. Chertow, Karl M. Johnson, Heinz Feldmann, David M. Morens
Annual Reviews of Pathology: Mechanism of Disease 2017; 12:387-418.
Ebola control: effect of asymptomatic infection and acquired immunity
Bellan SE, Pulliam JRC, Dushoff J, Meyers LA
The Lancet 2014; 384(9953):1499–1500.
The Role of Cytokines and Chemokines in Filovirus Infection
Viruses 2015 Oct;7(10):5489–5507.
Ebola Virus Infection Associated with Transmission from Survivors
Emerging Infectious Diseases 2019; 25:240-246.
Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic
Nature Immunology 2018; 19:20–28.
Recurrent Ebolavirus disease in the Democratic Republic of Congo: update and challenges
Public Health 2019;6(4):503-113.
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of
Ebola Viral Ribonucleic Acid in Semen and Breast Milk
Open Forum Infectious Diseases 2019; 6(12).
Ebola virus Disease: Focus on Children
The Pediatric Infectious Disease Journal 2015; 34(8):893-897.
Recurrence and reinfection—a new paradigm for the management of Ebola virus disease
International Journal of Infectious Diseases 2016; 43.
Human Ebola virus infection results in substantial immune activation
Proc Natl Acad Sci USA 2015 Apr 14;112(15):4719-24.
Correlates of vaccine-induced protective immunity against Ebola virus disease
Seminars in Immunology 2018; 39:65-72.
Ebola virus disease: Pathophysiology and Immunity
Current Topics in Microbiology and Immunology, vol 411.
Investigating the zoonotic origin of the West African Ebola epidemic
EMBO Mol Med 2015; 7:17-23.
Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April–May, 2018: an epidemiological
The Lancet 2018; 392.